Posted on 14/04/08
When an orphan drug is a patient's only hope
When Szymon Cajmer was six years old, he was denied entry into a clinical trial to test the only drug to treat his rare disease because his lungs worked too well. Now 11, he suffers from severe hearing loss and he easily loses his breath.
The full text of this article has 1130 words.
To continue reading this article, you will need to purchase this article.
Already have a member account? Login now
Pay-Per-View Offers To read the complete article, select one of the following options
Purchasing from globeandmail.com is quick and secure.
